| 000 | 02693nam a22003975i 4500 | ||
|---|---|---|---|
| 001 | 278127 | ||
| 003 | MX-SnUAN | ||
| 005 | 20160429153850.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 150903s2007 xxu| o |||| 0|eng d | ||
| 020 |
_a9780387499642 _99780387499642 |
||
| 024 | 7 |
_a10.1007/9780387499642 _2doi |
|
| 035 | _avtls000331801 | ||
| 039 | 9 |
_a201509030201 _bVLOAD _c201404121929 _dVLOAD _c201404091657 _dVLOAD _y201402041013 _zstaff |
|
| 040 |
_aMX-SnUAN _bspa _cMX-SnUAN _erda |
||
| 050 | 4 | _aRE1-994 | |
| 100 | 1 |
_aRhee, Douglas J. _eautor _9301481 |
|
| 245 | 1 | 0 |
_aOphthalmologic Drug Guide / _cby Douglas J. Rhee, Kathryn A. Colby, Christopher J. Rapuano, Lucia Sobrin. |
| 264 | 1 |
_aNew York, NY : _bSpringer New York, _c2007. |
|
| 300 |
_axii, 142 páginas _brecurso en línea. |
||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_acomputadora _bc _2rdamedia |
||
| 338 |
_arecurso en línea _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF _2rda |
||
| 500 | _aSpringer eBooks | ||
| 505 | 0 | _aAntibacterial Agents -- Antifungal Agents -- Antiviral Agents -- Antiparasitic Agents -- Antiglaucoma Agents -- Neuro-Ophthalmology -- Anti-Inflammatory Agents -- Mydriatics, Cycloplegics, and Reversal Agents -- Lubricants and Viscoelastics -- Miscellaneous Conditions -- Anti-Angiogenesis Agents -- Contact Lens Solutions. | |
| 520 | _aOphthalmology has long been considered a surgical area because so many disorders/diseases are treated surgically rather than medically. In the past ten years, however, there have been considerable therapeutic breakthroughs in non-surgical treatments. For instance, anti-glaucoma agents have becoming increasingly effective. This edition will include a new chapter for retinal disease. There are now several pharmaceutical agents being used to treat these diseases. Specifically, age-related macular degeneration has many new products – macugen, lucentis, etc. – and intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets have grown tremendously in the last 2-3 years (endura, restasis, xibrom, etc). | ||
| 590 | _aPara consulta fuera de la UANL se requiere clave de acceso remoto. | ||
| 700 | 1 |
_aColby, Kathryn A. _eautor _9301482 |
|
| 700 | 1 |
_aRapuano, Christopher J. _eautor _9301483 |
|
| 700 | 1 |
_aSobrin, Lucia. _eautor _9301484 |
|
| 710 | 2 |
_aSpringerLink (Servicio en línea) _9299170 |
|
| 776 | 0 | 8 |
_iEdición impresa: _z9780387332512 |
| 856 | 4 | 0 |
_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-0-387-49964-2 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL) |
| 942 | _c14 | ||
| 999 |
_c278127 _d278127 |
||